Skip to main content

Advertisement

SpringerLink
Log in

Risk of restless legs syndrome in low socioeconomic rheumatoid arthritis patients

  • Original Article
  • Published:
Modern Rheumatology

Abstract

Objectives

Our aim was to determine the frequency of restless leg syndrome (RLS) in rheumatoid arthritis (RA) patients from a low socioeconomic area of Pakistan and compare results with a control group to evaluate the effect of variables on RLS patients.

Methods

A clinical observational study was carried out on 240 RA patients form low socioeconomic group. Controls (n = 210) were frequency-matched by age group to the RA patients. We evaluated the presence of RLS and collected information on characteristics believed to be correlated with RLS in the general population. Multiple logistic regression models were used to study the association between RLS and other risk factors such as age, smoking status, and obesity.

Results

Among all rheumatic patients seen at our rheumatology clinic, 70.8 % were women. Our study shows that 20 % of RA patients were suffering from RLS compared with 10 % of the control group with other rheumatic diseases. Multivariate logistic regression adjusted for age, obesity, and smoking also showed that women with RA were more likely to have RLS than control patients. RLS was also significantly associated with increasing age, high body mass index, and smoking status.

Conclusions

Approximately 20 % of RA patients were suffering from RLS. Hence, there is need of increase awareness of RLS among rheumatologists to enhance early RLS diagnosis and appropriate management of this treatable condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. O’Keeffe ST. Restless legs syndrome. A review. Arch Intern Med. 1996;156:243–8.

    Article  PubMed  Google Scholar 

  2. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120(Suppl 1):S4–12.

    Article  PubMed  Google Scholar 

  3. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, et al. Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1. PLoS Genet. 2011;7(7):e1002171. doi:10.1371/journal.pgen.1002171.

    Article  PubMed  CAS  Google Scholar 

  4. Ohayon MM, et al. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2011;. doi:10.1016/j.smrv.2011.05.002.

    PubMed  Google Scholar 

  5. Sikandar R, Khealani BA, Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med. 2009;10(6):676–8.

    Article  PubMed  Google Scholar 

  6. Ishaq M, Muhammad JS, Hameed K, Mirza AI. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Mod Rheumatol. 2011;21:375–80.

    Article  PubMed  CAS  Google Scholar 

  7. Farooqi AZ, Gibson T. Prevalence of major rheumatic disorders in the adult population of northern Pakistan. Br J Rheum. 1998;37:491–5.

    Article  CAS  Google Scholar 

  8. Gudbjörnsson B, Broman JE, Hetta J, Hällgren R. Sleep disturbances in patients with primary Sjögren’s syndrome. Br J Rheumatol. 1993;32:1072.

    Article  PubMed  Google Scholar 

  9. Hassan N, Pineau CA, Clarke AE, et al. Systemic lupus and risk of restless legs syndrome. J Rheumatol. 2011;38:874.

    Article  PubMed  Google Scholar 

  10. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.

    Article  PubMed  CAS  Google Scholar 

  11. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol. 1994;33:60.

    Article  PubMed  CAS  Google Scholar 

  12. Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol. 2009;15:12–5.

    Article  PubMed  Google Scholar 

  13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.

    Article  PubMed  Google Scholar 

  14. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.

    Article  PubMed  Google Scholar 

  15. Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and resles legs syndrome in men and women. Neurology. 2009;72:1255–61.

    Article  PubMed  Google Scholar 

  16. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137–41.

    Article  PubMed  CAS  Google Scholar 

  17. Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13(Suppl 3):8–14.

    PubMed  Google Scholar 

  18. Kunas RC, McRae A, Kesselring J, Villiger PM. Antidopaminergic antibodies in a patient with complex autoimmune disorder and rapidly progressing Parkinson’s disease. J Allergy Clin Immunol. 1995;96:688–90.

    Article  PubMed  CAS  Google Scholar 

  19. Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Autoimmune-induced damage of midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:82–97.

    Article  Google Scholar 

  20. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the Risk of Restless Legs Syndrome in the General Population. Arch Intern Med. 2004; 164:196-20.

    Google Scholar 

  21. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137.

    Article  PubMed  CAS  Google Scholar 

  22. Hornyak M, Trendwalder C, Kohnen R, Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012;. doi:10.1016/j.sleep.2011.09.013.

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Medicine, Jinnah Medical College Hospital, Jinnah Medical and Dental College, Karachi, Pakistan

    Muhammad Ishaq & Jibran Sualeh Muhammad

  2. Department of Biological and Biomedical Sciences, The Aga Khan University, Faculty of Health Sciences, Medical College, Karachi, 74800, Pakistan

    Jibran Sualeh Muhammad

  3. Department of Medicine, Ziauddin Medical University, Karachi, Pakistan

    Kamran Hameed

Authors
  1. Muhammad Ishaq
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jibran Sualeh Muhammad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kamran Hameed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jibran Sualeh Muhammad.

About this article

Cite this article

Ishaq, M., Sualeh Muhammad, J. & Hameed, K. Risk of restless legs syndrome in low socioeconomic rheumatoid arthritis patients. Mod Rheumatol 23, 705–708 (2013). https://doi.org/10.1007/s10165-012-0714-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-012-0714-x

Keywords

Search

Navigation